Yuri Shimizu

3.5k citations
43 papers · 543 indexed · h-index 10
Topics
Immune Cell Function and Interaction (5 papers)Ovarian cancer diagnosis and treatment (4 papers)Virus-based gene therapy research (3 papers)

In The Last Decade

Yuri Shimizu

36 papers receiving 521 citations

Peers

Yuri Shimizu
Comparison fields: 5 of 92
  • Molecular Biology 282
  • Immunology 103
  • Cancer Research 83
  • Epidemiology 71
  • Oncology 62
Replace Riccardo Villa with:
Riccardo Villa Italy
Alisha M. Gruntman United States
Y. Millán Spain
Gisela Nilsson Sweden
Anne Thomas France
Fusayoshi Murata Japan
G Gheri Italy
A.B. Chepelinsky United States
Danielle M. Karyadi United States
Ann Hahnel Canada
Yuri Shimizu relative to Riccardo Villa Italy Riccardo Villa's profile →
Citations per field
00.5×2.6×
Riccardo Villa · 1×
Citations per year

Countries citing papers authored by Yuri Shimizu

Since Specialization
Citations

This map shows the geographic impact of Yuri Shimizu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuri Shimizu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuri Shimizu more than expected).

Fields of papers citing papers by Yuri Shimizu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuri Shimizu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuri Shimizu. The network helps show where Yuri Shimizu may publish in the future.

Co-authorship network of co-authors of Yuri Shimizu

This figure shows the co-authorship network connecting the top 25 collaborators of Yuri Shimizu. A scholar is included among the top collaborators of Yuri Shimizu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuri Shimizu. Yuri Shimizu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 0
4 4
5 0
6 3
7 74
8 4
9 6
10 32
11 1
12 2
13 46
14 6
15 3
16 62
17 0
18 4
19 1
20
Antiviral activities of silver sulfadiazine in ocular infection.
37

About Yuri Shimizu

Yuri Shimizu is a scholar working on Equine, Reproductive Medicine and Immunology, having authored 43 papers that have together received 543 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (5 papers), Ovarian cancer diagnosis and treatment (4 papers) and Virus-based gene therapy research (3 papers). The work is most often cited by research in Equine (19 citations), Cancer Research (83 citations) and Immunology (103 citations). Yuri Shimizu has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Shin‐Ichi Nishikawa, Takahiro Suzuki, Mami Kishima, Shiori Maeda, Hajime Nishimura, T. Tokumaru, Harukazu Suzuki, Erina Furuhata, Emmanuel Derudder and Marc Schmidt‐Supprian. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026